Related Experiment Video
Updated: May 30, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study
M Morelli1, G Arabia, F Novellino
1Institute of Neurology, University Magna Graecia, Germaneto, Catanzaro, Italy.
Neurology
|August 12, 2011
Summary
The Magnetic Resonance Parkinsonism Index (MRPI) effectively predicts progressive supranuclear palsy (PSP) in clinically unclassifiable parkinsonism (CUP) patients. MRPI demonstrated higher accuracy than clinical assessments in identifying PSP development.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Progressive Supranuclear Palsy (PSP) and Parkinson's Disease (PD) are distinct parkinsonian syndromes.
- Accurate diagnosis is crucial for appropriate management and treatment.
- Clinically Unclassifiable Parkinsonism (CUP) presents diagnostic challenges.
Purpose of the Study:
- To evaluate the Magnetic Resonance Parkinsonism Index (MRPI) for predicting PSP development in CUP patients.
- To compare MRPI's predictive accuracy against established clinical features.
Main Methods:
- A cohort of 45 CUP patients underwent baseline clinical evaluation and MRI with MRPI calculation.
- Patients were stratified into two groups based on MRPI values: normal (n=30) and suggestive of PSP (n=15).
- Clinical follow-up was conducted for all patients.
Main Results:
- None of the 30 CUP patients with normal MRPI developed PSP.
- 11 of 15 CUP patients with abnormal MRPI (suggestive of PSP) developed probable or possible PSP features.
- MRPI achieved 92.9% accuracy in predicting PSP, outperforming clinical features (e.g., vertical gaze palsy at 61.9%).
Conclusions:
- MRPI is a valuable tool for predicting the evolution of CUP towards PSP.
- MRPI offers superior predictive power compared to clinical assessments for identifying PSP phenotypes in challenging cases.
